Retrophin, the drug developer founded by jailed former biotech executive Martin Shkreli, has failed its first big test. The San Diego-based company?s experimental drug fosmetpantotenate failed a Phase 3 trial, FORT, in patients with a rare and deadly n… […]
Reports + Research UC San Diego Receives Grants to Uncover Cellular Cause of Type 1 Diabetes Type 1 diabetes is an autoimmune disease where a patient?s own immune system attacks the insulin-producing beta cells in the pancreas. These cells control bloo… […]
LA JOLLA?Light touch plays a critical role in everyday tasks, such as picking up a glass or playing a musical instrument. The sensation is also an essential part of the body?s protective defense system, alerting us to objects in our environment that co… […]
SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that five abstracts, including one late-breaker, highlighting data from its Cloudb… […]
LA JOLLA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) — DrugCendR, Inc., a clinical-stage biotech company developing next generation therapies for the treatment of solid tumors, today announced that Dr. Daniel Von Hoff will be a clinical advisor to the c… […]
SAN DIEGO–(BUSINESS WIRE)–#fasterscience–Inc. magazine today revealed that Scientist.com, the world?s largest enterprise marketplace for outsourced R&D services, ranked no. 289 on its Inc. 5000 list, the prestigious ranking of the nation?s faste… […]
Many facets of the finance industry, a highly regulated sector of the economy, are still reworking the tools used to move around money so that they fit a digital world. Digital mortgage lenders, for example, are having a field day, pulling in millions … […]
The California Institute for Regenerative Medicine (CIRM) has awarded a $4.96 million grant to Sanford Burnham Prebys Professor Evan Y. Snyder, M.D., Ph.D. The funding will allow Snyder to complete pre-investigational new drug (IND)-enabling studies, a… […]
A low-profile biotech founded by an exec with some deep roots in California biotech has mapped out plans for a very modest-sounding IPO.
Monopar Therapeutics is making a $40 million IPO play out of San Diego, where it?s been working on a handful of dru… […]
TuSimple, an autonomous trucking company, has been conducting test drives for UPS between the Arizona cities of Phoenix and Tucson since May. Now the corporate venture arm of the global package delivery giant says it has taken a minority stake in the S… […]
Just ahead of schedule the FDA has come through with a key approval for Genentech?s entrectinib ? now headed to the market as Rozlytrek.
Regulators approved the drug for ROS1-positive, metastatic non-small cell lung cancer as well as adult and pediatri… […]
Reports + Research San Diego Tops List of Best Work-Life Balance San Diego ranked highest for best work-life balance in a survey by Kisi. The survey compared data on work intensity, institutional support, legislation, and livability. According to the s… […]
Wireless giant Qualcomm has appointed Mark McLaughlin, the former CEO of network security company Palo Alto Networks, as chairman of its board of directors. McLaughlin joined Silicon Valley-based Palo Alto Networks (NYSE: PANW) as president and CEO in … […]
Sanford Burnham Prebys Medical Discovery Institute today announced a three-year extension to its existing collaboration with Eli Lilly and Company (Lilly) to discover and develop immunological therapies. […]
Scientists recently reported that two treatments saved the lives of people infected with the Ebola virus?with the New York Times reporting that roughly 90% of newly infected patients were saved?suggesting we are ever so close to a cure.?
To place this… […]
xMAP? Connect is a Luminex sponsored user group meeting where you will hear from multiplex experts about the development of cutting-edge methods and innovative projects from the research and clinical applications, as well as connect with fellow researc… […]